4D Molecular Therapeutics, Inc. reports

Company location: Emeryville, CA
Fiscal year end: 31 December

4D Molecular Therapeutics, Inc. has filed 421 SEC EDGAR filings since 13 Aug 2015

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 26-46 of 46 matching filings.

Per page

Current page

SC 13G/A File 005-91921

SC 13G/A

Filing date: 08 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A filing

Filing date: 31 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date: 21 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A filing

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A 4D MOLECULAR

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

JANUS HENDERSON GROUP PLC OWNS >5%

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A filing

Filing date: 09 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

SC 13G filing

Filing date: 04 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

SC 13G filing

Filing date: 04 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

THE SCHEDULE 13G

Filing date: 06 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SCHEDULE 13G/A

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

SC 13G

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

SC 13G

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

AMENDMENT NO. 1

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

4D MOLECULAR SC 13G

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

SC 13G filing

Filing date: 08 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

SCHEDULE 13G

Filing date: 23 Dec 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91921

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date: 21 Dec 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing